[1]杨莉丽,江丹玲,陈文科,等.克罗恩病患者血清总 25羟维生素 D及细胞因子水平表达与疾病活动指数的相关性研究[J].现代检验医学杂志,2022,37(01):195-198.[doi:10.3969/j.issn.1671-7414.2022.01.040]
　YANG Li-li,JIANG Dan-ling,CHEN Wen-ke,et al.Correlation Study on Serum Total 25-Hydroxyvitamin D and Cytokine Levels with Disease Activity Index in Patients withCrohn’s Disease[J].Journal of Modern Laboratory Medicine,2022,37(01):195-198.[doi:10.3969/j.issn.1671-7414.2022.01.040]
点击复制

克罗恩病患者血清总 25羟维生素 D及细胞因子水平表达与疾病活动指数的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年01期
页码:
195-198
栏目:
检验与临床
出版日期:
2022-01-15

文章信息/Info

Title:
Correlation Study on Serum Total 25-Hydroxyvitamin D and Cytokine Levels with Disease Activity Index in Patients withCrohn’s Disease
文章编号:
1671-7414（2022）01-195-04
作者:
杨莉丽; 江丹玲; 陈文科; 关幸求; 邹　兵
（北京大学深圳医院，广东深圳 518036）
Author(s):
YANG Li-li;  JIANG Dan-ling;  CHEN Wen-ke;  GUAN Xing-qiu;  ZOU Bing
（Peking University Shenzhen Hospital , Guangdong Shenzhen 518036,China）
关键词:
克罗恩病; 疾病活动指数; 总 25-羟基维生素 D; 细胞因子
分类号:
R572；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.01.040
文献标志码:
A
摘要:
目的　探讨克罗恩病患者血清总 25羟基维生素 D、细胞因子白介素 6（IL-6）、白介素 8（IL-8）和肿瘤坏死因子α（ TNF-α）在克罗恩病不同时期的表达水平以及其与疾病活动指数（ CDAI）的相关性。方法　选取 2018年 1月～ 2020年 12月在北京大学深圳医院就诊的克罗恩病患者共 100例纳入研究。收集患者的空腹静脉血，检测总 25羟基维生素 D，IL-6，IL-8和 TNF-α水平；采用 CDAI评估患者疾病活动情况，并根据 CDAI评分将患者分为四组，缓解期 21例，轻度活动期 32例，中度活动期 29例和重度活动期 18例。比较 CDAI评分不同分期患者的血清总 25-羟基维生素 D，IL-6，IL-8和 TNF-α的表达水平。并进一步分析比较患者 CDAI与血清总 25-羟基维生素 D水平及细胞因子 IL-6，IL-8及 TNF-α表达水平之间的相关性。结果　四组患者血清总 25-羟基维生素 D及细胞因子 IL-6，IL-8和 TNF-α的差异均存在统计学意义（F=34.281～ 128.53，均 P<0.05）。缓解期患者血清总 25-羟基维生素 D（23.49±3.46μg/
Abstract:
Objective　 To investigate the expression levels of serum total 25-hydroxyvitamin D, cytokines interleukin-6 (IL-6),interleukin-8 (IL-8) and tumor necrosis factor α (TNF-α) in patients with Crohn’s disease at different stages of Crohn’s diseaseand their correlation with Crohn’s disease activity index (CDAI). Methods　A total of 100 patients with Crohn’s disease whowere treated at Peking University Shenzhen Hospital from January 2018 to December 2020 were included in the study. Fastingvenous blood of the patients was collected, and the levels of total 25-hydroxyvitamin D, IL-6, IL-8 and TNF-α were determined.Crohn’s disease activity index (CDAI) was used to evaluate patients’ disease activity. According to CDAI score, the patients weredivided into four groups, 21 cases in remission stage, 32 cases in mild active stage, 29 cases in moderate active stage, and 18 casesin severe active stage. The expression levels of serum total 25-hydroxyvitamin D, IL-6, IL-8 and TNF-α in patients with differentCDAI scores were compared. The correlation between CDAI and serum total 25-hydroxyvitamin D levels and the expressionlevels of cytokines IL-6, IL-8 and TNF-α was further analyzed and compared. Results　 There were significant statisticaldifferences in serum total 25-hydroxyvitamin D and cytokines IL-6, IL-8 and TNF-α among 4 groups (F=34.281~128.53,P<0.05). The serum levels of total 25-hydroxyvitamin D (23.49±3.46μg/L), IL-8 (86.39±11.23ng/L) and TNF-α(24.05±2.12ng/L) in patients in remission stage were significantly higher than those in the other three groups (mild activity stage:19.47±2.83μg/L, 70.48±9.48ng/L and 20.59±3.22ng/L. Moderately active stage: 14.30±2.64μg/L, 65.38±10.91ng/Land 17.48±4.12ng/L. Severe active stage: 11.39±3.93μg/L and 46.58±12.32ng/L, 13.44±3.98ng/L), but the level of IL-6(4.37±0.78ng/L) was significantly lower than that in the other three groups (6.48±1.12ng/L in mild active stage,65.38±10.91ng/L in moderate active stage, 46.58±12.32ng/L in severe active stage), the differences were statistically significant(all P<0.05). Spearman correlation analysis showed that CDAI was negatively correlated with serum total 25-hydroxyvitamin D(R=-0.691, P<0.05) and positively correlated with cytokine IL-6 (r=0.889, P<0.05) in Crohn’s disease patients. And it wassignificantly negatively correlated with IL-8 and TNF-α (r=-0.675, -0.658, all P<0.05). Conclusion　There were significantdifferences in total 25-hydroxyvitamin D and cytokine levels among patients with Crohn’s disease at different disease activitystages. Serum IL-6 levels were positively correlated with disease activity, while total 25-hydroxyvitamin D, IL-8 and TNF-αlevels were negatively correlated with disease activity.

参考文献/References:

[1] 朱益佳, 宁明哲, 杨平, 等. 血清炎症性肠病抗体谱的检测对IBD 诊断及鉴别诊断的临床价值[J]. 现代检验医学杂志，2017,32(1):141-143.ZHU Yijia, NING Mingzhe, YANG Ping, et al.Clinical value of diagnosis and differential diagnosisof detection of serum inflammatory bowel diseaseantibody spectrum in IBD[J].Journal of ModernLaboratory Medicine, 2017, 32(1): 141-143.
[2] NAGAYAMA M, YANO T, ATARASHI K, et al. TH1cell-inducing Escherichia coli strain identified fromthe small intestinal mucosa of patients with Crohn’sdisease[J]. Gut Microbes, 2020, 12(1): 1788898.
[3] 汪海潮, 叶晨, 吴亚玲, 等. 克罗恩病患者合并肠外表现的临床特征及相关因素分析[J]. 中华炎性肠病杂志, 2020, 4(3):206-211.WANG Haichao, YE Chen, WU Yaling, et al. Clinicalcharacteristics and factors related to extraintestinalmanifestations in patients with Crohn’s disease [J].Chinese Journal of Inflammatory Bowel Diseases,2020, 4(3):206-211.
[4] 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018 年, 北京)[J]. 中华消化杂志, 2018, 38(5):292-311.Inflammatory Bowel Disease Group, Chinese Societyof Gastroenterology，Chinese Medical Association.Chinese consensus on diagnosis and treatment ofinflammatory bowel disease (Beijing, 2018) [J].Chinese Journal of Digestion, 2018, 38(5):292-311.
[5] BEST W R, BECKTEL J M, SINGLETON J W,et al. Development of a Crohn’s disease activityindex. National cooperative crohn’s disease study[J].Gastroenterology, 1976, 70(3): 439-444.
[6] VALVANO M, MAGISTRONI M, MANCUSI A, etal. The usefulness of serum vitamin D levels in theassessment of IBD activity and response to biologics[J].Nutrients, 2021, 13(2): 323.
[7] BATTISTINI C, BALLAN R, HERKENHOFF M E,et al. Vitamin D modulates intestinal microbiota ininflammatory bowel diseases[J]. International Journalof Molecular Sciences, 2020, 22(1): 362.
[8] GISBERT-FERR?NDIZ L, SALVADOR P, ORTIZMASI?D, et al. A single nucleotide polymorphismin the vitamin D receptor gene is associated withdecreased levels of the protein and a penetrating patternin Crohn’s disease[J]. Inflammatory Bowel Diseases,2018, 24(7): 1462-1470.
[9] BENDIX M, DIGE A, J?RGENSEN S P, et al. Sevenweeks of high-dose vitamin D treatment reduces theneed for infliximab dose-escalation and decreasesinflammatory markers in Crohn’s disease during oneyearfollow-up[J]. Nutrients, 2021, 13(4): 1083.
[10] 尤国莉, 沈阳, 刘翠, 等. 维生素D 对克罗恩病患者铁调节蛋白和炎性因子的影响[J]. 国际消化病杂志,2020,40(5): 298-302，329.YOU Guoli, SHEN Yang, LIU Cui, et al. Effect ofvitamin D on iron regulatory protein and inflammatoryfactors in patients with Crohn’s disease [J].International Journal of Digestive Diseases, 2020,40(5):298-302，329.
[11] 张宪波，刘月皎，陈云峰．粪便钙卫蛋白在肠易激综合征和炎症性肠病鉴别诊断中的意义分析[J]. 现代检验医学杂志, 2021, 36(1): 124-127.ZHANG Xianbo, LIU Yuejiao, CHEN Yunfeng.Significance of fecal calprotectin in differentialdiagnosis of irritable bowel syndrome and inflammatorybowel disease [J]. Journal of Modern LaboratoryMedicine, 2021, 36(1): 124-127.
[12] ZHENG Wanwei, SONG Huan, LUO Zhongguang, etal. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressorcells through the nAChR/ERK pathway[J]. Proceedingsof the National Academy of Sciences of the UnitedStates of America, 2021, 118(11): e2017762118.
[13] DI LIBERTO D, SCAZZONE C, LA ROCCA G, etal. Vitamin D increases the production of IL-10 byregulatory T cells in patients with systemic sclerosis[J].Clinical and Experimental Rheumatology, 2020, 38(6):1276.
[14] 陈丹, 李骥, 张鑫垚, 等. 克罗恩病患者维生素D 水平与细胞因子的相关性研究[J]. 中华医学杂志,2020,100(10):757-762．CHEN Dan, LI Ji, ZHANG Xinyao, et al. Study ofthe correlation between vitamin D status and cytokinelevels in patients with Crohn’s disease[J]. NationalMedical Journal of China, 2020, 100(10):757-762.
[15] BERTANI L, CAVIGLIA G P, ANTONIOLI L, et al.Serum interleukin-6 and -8 as predictors of responseto vedolizumab in inflammatory bowel diseases[J].Journal of Clinical Medicine, 2020, 9(5): 1323.
[16] SU Yanzhuo, ZHAO Haomin. Predisposition ofinflammatory bowel disease is influenced by IL-8, IL-10, and IL-18 polymorphisms: a meta-analysis[J].International Archives of Allergy and Immunology,2020, 181(10): 799-806.
[17] 杨贝贝, 王许平, 王丹丹, 等.RANKL/OPG 系统及白细胞介素8 在炎症性肠病中的表达及作用研究[J].胃肠病学和肝病学杂志, 2019, 28(4):434-438.YANG Beibei, WANG Xuping, WANG Dandan, et al.RANKL / OPG system and interleukin-8 in inflammatorybowel disease [J]. Chinese Journal of Gastroenterologyand Hepatology, 2019, 28(4):434-438.
[18] 邓雳, 毛成荣, 赵家文. 血清TNF-α,IL-35 在炎症性肠病患者中的表达及临床价值[J]. 河北医药,2020, 42(2):295-297.DENG Li, MAO Chengrong, ZHAO Jiawen. Theexpression and clinical significance of serum TNF-αlpha and IL-35 in patients with inflammatory boweldisease [J]. Hebei Medical Journal, 2020, 42(2):295-297.
[19] 李青霞, 刘立新, 郭晓红. 抗TNF-α 制剂降阶梯治疗克罗恩病的疗效与安全性的Meta 分析[J]. 山西医科大学学报,2020,51(12):1383-1388.LI Qingxia, LIU Lixin, GUO Xiaohong. Efficacy andsafety of anti-TNF-αagents in the top-down treatmentof Crohn’s disease:a meta-analysis [J]. Journal ofShanxi Medical University, 2020, 51(12): 1383-1388.
[20] GREUTER T, MAILLARD M H, JUILLERAT P, et al.Therapeutic drug monitoring to guide clinical decisionmaking in inflammatory bowel disease patients withloss of response to anti-TNF: A delphi Technique-Basedconsensus[J]. Digestion, 2020, 101(6): 683-691.

相似文献/References:

[1]王平均a,孙灵迪b,武晓茜b,等.HLA-B27表达量在评估强直性脊柱炎患者疾病状况中的作用[J].现代检验医学杂志,2015,30(05):153.[doi:10.3969/j.issn.1671-7414.2015.05.049]
　WANG Ping-juna,SUN Ling-dib,WU Xiao-qianb,et al.Roles of the Expression Intensity of HLA-B27 in Estimating Patients with Ankylosing Spondylitis[J].Journal of Modern Laboratory Medicine,2015,30(01):153.[doi:10.3969/j.issn.1671-7414.2015.05.049]
[2]王 燕a,胡秀娟a,张 丽a,等.溃疡性结肠炎患者血清Elabela，LRG1水平表达与疾病活动指数的相关性研究[J].现代检验医学杂志,2024,39(01):100.[doi:10.3969/j.issn.1671-7414.2024.01.018]
　WANG Yana,HU Xiujuana,ZHANG Lia,et al.Correlation between the Expression of Serum Elabela, LRG1 Levels and Disease Activity Index in Patients with Ulcerative Colitis[J].Journal of Modern Laboratory Medicine,2024,39(01):100.[doi:10.3969/j.issn.1671-7414.2024.01.018]

备注/Memo

备注/Memo:
基金项目：深圳市科技计划项目（项目编号：JCYJ20150403091443320）。
作者简介：杨莉丽（1978-），女，硕士，副主任医师，主研方向：功能性胃肠病。
通讯作者：邹兵，主任医师，E-mail：gfweuig1234@163.com。
更新日期/Last Update: 1900-01-01